Originally published January 12 2006
Kentucky researchers develop early detection profile for lung cancer
by Mike Adams, the Health Ranger, NaturalNews Editor
Researchers at the University of Kentucky's Chandler Medical Center have developed a successful profiling technique for early detection of lung cancer by looking for five cancer-associated antibody proteins.
A promising new antibody profiling technique offers a high degree of accuracy in the early diagnosis of non-small cell lung cancer, a new U.S. study finds.
Researchers at the University of Kentucky's Chandler Medical Center in Lexington, Ky., analyzed 212 candidate markers and eventually narrowed that down to the five most predictive cancer-associated antibody proteins.
Using these proteins, they were able to achieve over 90 percent accuracy in spotting cancerous and cancer-free samples from patients.
Currently, only 25 percent of new lung cancer cases are diagnosed at an early stage, when it's possible to perform curative surgery, the researchers noted.
"Potential uses [of the screen] include early detection or screening, differentiation of benign from malignant disease, differentiating histologies, defining stages and responses to therapy, and defining prognosis," lead researcher Li Zhong said in a prepared statement.
The findings were reported in the November issue of the American Journal of Respiratory and Critical Care Medicine.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml